CSS
EW icon

Cubist Systematic Strategies’s Edwards Lifesciences EW Stock Holding History

Cubist Systematic Strategies’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.17M Hold
15,100
– – 0.01% 1866
2025
Q2 		$1.18M Sell
15,100
-5,400
-26% -$403K 0.01% 1856
2025
Q1 		$1.49M Sell
20,500
-47,600
-70% -$3.41M 0.01% 1593
2024
Q4 		$5.04M Buy
68,100
+15,700
+30% +$1.1M 0.03% 833
2024
Q3 		$3.46M Buy
52,400
+50,200
+2,282% +$3.65M 0.02% 1077
2024
Q2 		$203K Sell
2,200
-35,900
-94% -$3.18M ﹤0.01% 2500
2024
Q1 		$3.64M Sell
38,100
-2,200
-5% -$185K 0.02% 1188
2023
Q4 		$3.07M Buy
40,300
+28,800
+250% +$2M 0.02% 1182
2023
Q3 		$797K Sell
11,500
-10,700
-48% -$860K 0.01% 2032
2023
Q2 		$2.09M Sell
22,200
-66,400
-75% -$5.77M 0.01% 1454
2023
Q1 		$7.33M Sell
88,600
-16,800
-16% -$1.32M 0.04% 655
2022
Q4 		$7.86M Buy
105,400
+77,100
+272% +$5.94M 0.05% 648
2022
Q3 		$2.34M Buy
+28,300
New +$2.72M 0.01% 1846

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Cubist Systematic Strategies's EW Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Edwards Lifesciences (EW) stake by 86% in Q3 2025, selling an estimated $5.31M and leaving 11,525 shares worth $896K. The position accounts for ﹤0.01% of the portfolio, ranked #1989.

Cubist Systematic Strategies first reported a position in EW in Q2 2014 and has held it in 41 quarters since. The position peaked at $26.1M in Q4 2022. 1,253 funds tracked by Wall St. Rank hold EW as of Q3 2025.

  • Cubist Systematic Strategies held 11,525 shares of Edwards Lifesciences worth $896K as of Q3 2025.
  • Cubist Systematic Strategies sold 67,978 Edwards Lifesciences shares in Q3 2025, an estimated $5.31M.
  • Edwards Lifesciences made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #1989 holding.
  • Cubist Systematic Strategies first reported a position in Edwards Lifesciences in Q2 2014 and has held it in 41 quarters since.
  • Cubist Systematic Strategies's Edwards Lifesciences position peaked at $26.1M in Q4 2022.
  • 1,253 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.